Credit Suisse Downgrades Infinity Pharmaceutical (INFI) to Neutral

December 12, 2013 6:41 AM EST Send to a Friend
Get Alerts INFI Hot Sheet
Price: $15.96 --0%

Rating Summary:
    10 Buy, 6 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 11 | Down: 28 | New: 24
Trade INFI Now!
Join SI Premium – FREE
Credit Suisse downgraded Infinity Pharmaceutical (NASDAQ: INFI) from Outperform to Neutral with a price target of $20.00 (unchanged).

For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.

Shares of Infinity Pharmaceutical closed at $13.31 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Credit Suisse

Add Your Comment